Company · founded 2009
Phusis Therapeutics (United States)
San Diego, United States · phusistherapeutics.com
- Citations, last 5 years
- 47
- Works, last 5 years
- 1
- h-index
- 26
- Scientists listed
- 0
- Grants since 2016
- 6
Grants received
2025–2027 · research · R44
Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses
Garth Powis · Phusis Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R21
Targeting ERK5 for Colorectal Cancer Therapy
Garth Powis · Phusis Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Development of a novel therapeutic for treatment of white matter injury in premature infants
Jason E Kralic · Phusis Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Development of a novel therapeutic for treatment of white matter injury in premature infants
Jason E Kralic · Phusis Therapeutics (United States) · funded by National Institutes of Health
2018–2023 · research · R01
Inhibiting Multi-Functional ALDOA for Cancer Therapy
Garth Powis · Phusis Therapeutics (United States) · funded by National Institutes of Health
2018–2025 · research · R01
Inhibiting Multi-Functional ALDOA for Cancer Therapy
Garth Powis · Phusis Therapeutics (United States) · funded by National Institutes of Health
